Amarantus Biosci (AMBS) Stock Statistics & Valuation Metrics
Total Valuation
Amarantus Biosci has a market cap or net worth of $630.00. The enterprise value is $19.18T.
- Market Cap
- $630.00
- Enterprise Value
- $19.18T
Share Statistics
Amarantus Biosci has 630,407,400 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 630,407,400
- Owned by Insiders
- ―
- Owned by Institutions
- <0.01%
Financial Efficiency
Amarantus Biosci’s return on equity (ROE) is 0.19 and return on invested capital (ROIC) is 4.85%.
- Return on Equity (ROE)
- 0.19
- Return on Assets (ROA)
- -0.47
- Return on Invested Capital (ROIC)
- 4.85%
- Return on Capital Employed (ROCE)
- 0.01
- Revenue Per Employee
- 7,944.25
- Profits Per Employee
- -396.83K
- Employee Count
- 12
- Asset Turnover
- 0.01
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Amarantus Biosci is -0.01. Amarantus Biosci’s PEG ratio is -0.00.
- PE Ratio
- -0.01
- PS Ratio
- 0.39
- PB Ratio
- -0.00
- Price to FCF
- -0.01
- Price to Operating Cash Flow
- -0.01
- PEG Ratio
- -0.00
Income Statement
In the last 12 months, Amarantus Biosci had revenue of 95.33K and earned -4.76M in profits. Earnings per share was -0.01.
- Revenue
- 95.33K
- Gross Profit
- 95.33K
- Operating Income
- -268.00K
- Pretax Income
- -4.76M
- Net Income
- -4.76M
- EBITDA
- -4.53M
- Earnings Per Share (EPS)
- -0.01
Cash Flow
In the last 12 months, operating cash flow was -1.49M and capital expenditures 0, giving a free cash flow of -1.49M billion.
- Operating Cash Flow
- -1.49M
- Free Cash Flow
- -1.49M
- Free Cash Flow per Share
- -0.01
Dividends & Yields
Amarantus Biosci pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -12212.77%
- Earnings Yield
- -8215.91%
Stock Price Statistics
- Beta
- 120.57
- 52-Week Price Change
- 20.00%
- 50-Day Moving Average
- ―
- 200-Day Moving Average
- ―
- Relative Strength Index (RSI)
- ―
- Average Volume (3m)
- ―
Financial Position
Amarantus Biosci as a current ratio of 0.00, with Debt / Equity ratio of -77.60%
- Current Ratio
- 0.00
- Quick Ratio
- 0.00
- Debt to Market Cap
- 19.42
- Net Debt to EBITDA
- -4.22
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Amarantus Biosci has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Amarantus Biosci EV to EBITDA ratio is -4.23, with an EV/FCF ratio of -4.26.
- EV to Sales
- 201.15
- EV to EBITDA
- -4.23
- EV to Free Cash Flow
- -4.26
- EV to Operating Cash Flow
- -4.26
Balance Sheet
Amarantus Biosci has $0.00 in cash and marketable securities with $19.12M in debt, giving a net cash position of -$19.12M billion.
- Cash & Marketable Securities
- $0.00
- Total Debt
- $19.12M
- Net Cash
- -$19.12M
- Net Cash Per Share
- -$0.03
- Tangible Book Value Per Share
- -$0.04
Margins
Gross margin is 100.00%, with operating margin of -281.13%, and net profit margin of -4995.23%.
- Gross Margin
- 100.00%
- Operating Margin
- -281.13%
- Pretax Margin
- -4995.23%
- Net Profit Margin
- -4995.23%
- EBITDA Margin
- -4755.55%
- EBIT Margin
- -4995.23%
Analyst Forecast
The average price target for Amarantus Biosci is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- 0
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- ―